Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Understanding allergic reactions: chronicling the work of Dr Teruko Ishizaka
  2. Progress made in developing first Chlamydia vaccine
  3. Psoriasis Action Month: using genetics to improve drug development
  4. Sanofi’s Dupixent met study endpoints in children with atopic dermatitis
  5. Verona announces positive results for DPI form of COPD drug

Latest Content

Progress made in developing first Chlamydia vaccine

Researchers from Statens Serum Institut (SSI), Denmark, and Imperial College London have published promising results from the first clinical trial of a vaccine for Chlamydia, the most common sexually transmitted disease.

Psoriasis Action Month: using genetics to improve drug development

The role of a patient’s genes in causing inflammatory skin condition psoriasis has been largely accepted in the medical community over the past few decades. This has led to significant research into precisely which genes are associated with the condition and how this understanding can better inform drug development, as well as ensure there are effective treatments for more patients.

Unprecedented global demand for Gardasil 9

The widening commercial frontier for Gardasil 9 is a reflection of evolving vaccination objectives across the globe and presents an opportunity to decrease or potentially eliminate HPV-related cancers worldwide

Pharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction

This white paper explores a number of ways that today's modern, laboratory-based powder x-ray diffraction (PXRD) instrumentation and advanced software can greatly assist pharmaceutical scientists in their quest to develop high-quality, stable products and accelerate their speed-to-market.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:


Go Top